Franklin Resources
TCRT icon

Franklin Resources’s Alaunos Therapeutics TCRT Stock Holding History

Franklin Resources’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-720
Closed -$7.63K – 2961
2023
Q4 		$7.63K Hold
720
– – ﹤0.01% 2609
2023
Q3 		$14.2K Sell
720
-186
-21% -$8.01K ﹤0.01% 2611
2023
Q2 		$69.3K Hold
906
– – ﹤0.01% 2583
2023
Q1 		$85.6K Hold
906
– – ﹤0.01% 2131
2022
Q4 		$88.2K Hold
906
– – ﹤0.01% 2144
2022
Q3 		$234K Buy
906
+14
+2% +$4.07K ﹤0.01% 1946
2022
Q2 		$166K Buy
+892
New +$85.2K ﹤0.01% 2057

Other funds holding TCRT

MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACM
Allred Capital Management Dallas, Texas $275M AUM 18.19% 1-Year Est. Return

Franklin Resources's TCRT Position: Q1 2024 in Review

Franklin Resources sold out of Alaunos Therapeutics (TCRT) in Q1 2024, closing a stake of 720 shares — an estimated $7.63K sold.

Franklin Resources first reported a position in TCRT in Q2 2022 and held it in 7 quarters. The position peaked at $234K in Q3 2022. 45 funds tracked by Wall St. Rank hold TCRT as of Q1 2024.

  • Franklin Resources reported no remaining Alaunos Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Franklin Resources sold 720 Alaunos Therapeutics shares in Q1 2024, an estimated $7.63K.
  • Franklin Resources first reported a position in Alaunos Therapeutics in Q2 2022 and held it in 7 quarters.
  • Franklin Resources's Alaunos Therapeutics position peaked at $234K in Q3 2022.
  • 45 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q1 2024.

Based on Franklin Resources's 13F filing for Q1 2024, filed 13 May 2024.